2294 part 1 final report.pdf - Agra CEAS Consulting
2294 part 1 final report.pdf - Agra CEAS Consulting
2294 part 1 final report.pdf - Agra CEAS Consulting
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Prevention and control of animal diseases worldwide<br />
Part I: Economic analysis: prevention versus outbreak costs<br />
6. Global overview<br />
6.1. Overall approach and objectives<br />
We have structured the overview as a global analysis of prevention costs versus outbreak costs. While the<br />
costs of prevention are relatively well documented in the estimates provided, for example in the case of<br />
HPAI by the competent international bodies on their worldwide needs assessments (section 4.2), the world<br />
wide direct and indirect impact of an animal disease has not yet been analysed as such. Estimating these<br />
costs would allow drawing conclusions on the expected potential benefits of investing in improved<br />
prevention, as well as on the anticipated scale of the direct production control costs and losses which is of<br />
use to <strong>part</strong> II of the analysis.<br />
To fill this gap, we have developed a specific analytical tool incorporating a baseline, scenarios and<br />
assumptions on key parameters from which to estimate the detailed direct and indirect costs of a disease<br />
outbreak.<br />
It is important to note that the aim here has been to develop a flexible tool, rather than solely providing<br />
estimates as such. This means that the baseline, the assumptions and the scenarios can be<br />
improved/refined at any point in time, as further research and evidence on a disease impact becomes<br />
available. This tool allows a flexible approach, which highlights the relative importance of the various<br />
direct and indirect impacts, so as to provide direction to policy-making in this field.<br />
In this <strong>report</strong> this tool has been developed specifically for the case of HPAI, but it has the potential to be<br />
adapted for application in the case of other TADs. In the case of HPAI, the available research to date as<br />
well as the nature of the disease and its economic impacts allows a more detailed approach for the<br />
calculation of worldwide direct and indirect impacts. In the case of FMD, the available evidence is largely<br />
sporadic, in that it is based on specific measures and countries/regions, and is therefore heavily dependent<br />
on specificities which do not allow sensible extrapolations to be made at a world level (as discussed in<br />
section 4.4). However, this tool could be easily adapted to derive estimates of the worldwide effects of<br />
FMD when such research and evidence becomes available. In the meantime we have used the experience<br />
of Argentina and the wider Latin America region from our case study, to draw some conclusions on<br />
prevention versus outbreak costs.<br />
6.2. Economic analysis of outbreak costs<br />
The analytical tool, as developed and applied in the case of HPAI, is attached as a separate spreadsheet<br />
file (Annex 5). The following sections describe the parameters used, the applied baseline, scenarios and<br />
assumptions, and the derived estimates 136 .<br />
136 The layout of the spreadsheet is detailed in the “READ ME FIRST” worksheet.<br />
Civic <strong>Consulting</strong> • <strong>Agra</strong> <strong>CEAS</strong> <strong>Consulting</strong> 139